VEGFA and neoplasm: NK cell proliferation and antitumor activity are reduced by the release of different immunosuppressive substances by tumor cells, including prostaglandin E2, indoleamine 2,3-dioxygenase (IDO), IL-10, TGF-β and vascular endothelial growth factor (VEGF) [108].